We have been trying to stimulate ERK1/2 activation in MCF-7 cells (as detected by ERK1/2 phosphorylaton) with this pharmacological GPER (GPR30 ligand). So far without any success, although positive control (EGF) works pretty good. Can anybody recommend optimum exposure time or working concentration for this lignand? Or, should we select a bettter, alternative endpoint to measure? We also tried alternative activators reported in literature, such as genistein, also without any success.

More Jan Vondracek's questions See All
Similar questions and discussions